Genta Postscript: Defunct Company’s Former President Charged With Insider Trading
This article was originally published in The Pink Sheet Daily
Executive Summary
Loretta Itri told a longtime friend of the negative results of a Phase III study of Genasense in advanced melanoma before the news was public.